Identification of a Second Collagen-Like Glycoprotein Produced by Bacillus anthracis and Demonstration of Associated Spore-Specific Sugars by Waller, Lashanda N. et al.
JOURNAL OF BACTERIOLOGY, July 2005, p. 4592–4597 Vol. 187, No. 13
0021-9193/05/$08.000 doi:10.1128/JB.187.13.4592–4597.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Identification of a Second Collagen-Like Glycoprotein Produced by
Bacillus anthracis and Demonstration of Associated
Spore-Specific Sugars
Lashanda N. Waller,1 Michael J. Stump,1 Karen F. Fox,1 William M. Harley,1 Alvin Fox,1*
George C. Stewart,2 and Mona Shahgholi3
Department of Pathology and Microbiology, University of South Carolina School of Medicine, Columbia,
South Carolina 292081; Department of Veterinary Pathobiology, University of Missouri, Columbia,
Missouri 652112; and Division of Chemistry and Chemical Engineering, California
Institute of Technology, Pasadena, California 911255-30003
Received 7 February 2005/Accepted 28 March 2005
Certain carbohydrates (rhamnose, 3-O-methyl rhamnose, and galactosamine) have been demonstrated to be
present in Bacillus anthracis spores but absent in vegetative cells. Others have demonstrated that these spore-
specific sugars are constituents of the glycoprotein BclA. In the current work, spore extracts were separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A second collagen-like glycoprotein, BclB, was
identified in B. anthracis. The protein moiety of this glycoprotein was identified by matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MS) and the carbohydrate components by gas chro-
matography-mass spectrometry and tandem mass spectrometry. Spore-specific sugars were also demonstrated
to be components of BclB.
Anthrax is a fatal disease caused by the gram-positive, rod-
shaped bacterium Bacillus anthracis. The most lethal form of
human anthrax is pulmonary (26). Inhaled spores are trans-
mitted through the air and are deposited in the lungs. The
spore is resistant to harsh environmental conditions, including
exposure to ultraviolet light, heat, desiccation, and organic
solvents (39). In vitro spores are engulfed by alveolar macro-
phages, where they germinate, although it remains to be dem-
onstrated whether germination must occur within macro-
phages for induction of anthrax in vivo (5, 12, 13, 26). The
outer surfaces surrounding the spore, including the coat and
exosporium (1, 16, 19, 24, 29, 30), might play a role in envi-
ronmental protection and/or pathogenesis.
During sporulation, the vegetative cell divides asymmetri-
cally and the mother cell engulfs the smaller cell that becomes
the forespore. The spore cortex, unlike vegetative peptidogly-
can, has not been shown to possess a covalently bound poly-
saccharide. Furthermore, muramic acid is found in both the
cortex and vegetative peptidoglycan, but muramic acid delta
lactam is exclusive to the spore (34). In the vegetative cell, S
protein and poly-D-glutamic acid capsule constitute the outer-
most layers. However, in the spore, the coat and exosporium
surround the cortex (6). After the spore is formed, autolytic
enzymes digest the vegetative mother cell and the spore is re-
leased.
The spore surface is characterized by an external exospor-
ium consisting of a basal layer surrounded by a nap of hair-like
projections (14, 15). The first spore surface protein, BclA (Ba-
cillus, collagen-like protein of anthracis), was discovered in
B. anthracis (29, 30). BclA is localized to the exosporium nap
as demonstrated by monoclonal antibody labeling. The peptide
backbone has a predicted size of approximately 39 kDa, but the
intact protein migrates with an apparent mass of250 kDa for
the Sterne strain, which is consistent with its being heavily gly-
cosylated (30). It is entirely possible that there may be addi-
tional protein modifications. The genetic region coding for the
peptide backbone varies in length among strains since it codes
for variable numbers of collagen-like tandem repeats (31).
Other exosporium glycoproteins, ExsJ and ExsH, have been
identified in Bacillus thuringiensis (10) and Bacillus cereus (3,
18, 32). Both ExsJ and ExsH have both been reported to mi-
grate, during electrophoresis, as 205-kDa species. Within the
spores of B. thuringiensis, rhamnose, galactosamine, and a third
unidentified sugar were shown to be components of ExsJ. ExsH
has a region of collagen-like repeats, like ExsJ, but the carbohy-
drate composition of ExsH has not been determined. ExsH-like
proteins have not been previously identified in B. anthracis.
The spores of B. anthracis (8) and related bacilli (38) contain
carbohydrate monomers that are absent in vegetative cells.
Spores and isolated exosporium contain two rhamnose oligo-
saccharides, penta- and trisaccharides, respectively (4). Both
contain the spore-specific sugars 3-O-methyl rhamnose, rham-
nose, galactosamine, and anthrose (4). The exosporium of
BclA mutants contains much lower levels of these carbohy-
drates. This clearly demonstrates that BclA is the major spore
glycoprotein. However, it is entirely possible that another mi-
nor glycoprotein may have not been detected in these studies.
Mutants that have BclA genes coding for BclA with shortened
tandem repeat regions contain proportionately less of the pen-
tasaccharide in the exosporium, although the amount of the
trisaccharide is unaffected (4). It has been reported that the
trisaccharide may not be linked to the repeat region (4) or al-
ternatively it is suggested here that it may be present in a sec-
ond glycoprotein.
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In the current report, it is demonstrated that the anthrax
spore contains a second collagen-like glycoprotein, having tan-
dem repeats as are found in BclA and ExsH. Since it is dem-
onstrated here that spore-specific sugars previously shown to
be a component of BclA of B. anthracis are also found in this
newly discovered protein, we have chosen to name it BclB.
MATERIALS AND METHODS
Growth conditions and preparation of cells for analysis. Bacillus anthracis
strain Sterne-1 was a gift from S. H. Leppla (National Institutes of Health,
Bethesda, MD). Sterne-1 is a strain derived from Sterne and lacking pXO1 and
pXO2. Generally growth was on nutrient agar plates (Difco, Detroit, MI), and
vegetative cells were harvested within 20 h before sporulation occurred (i.e.,
99% vegetative). Sporulation was essentially complete after 48 h (95%).
Samples were stored frozen overnight and then thawed. The spores were then
incubated at room temperature for 1 to 2 h to lyse remaining vegetative cells,
when preparations were 99% spores. The degree of sporulation was assessed
by either malachite green staining or phase contrast microscopy.
The spores or vegetative cells were harvested by centrifugation, washed three
times in distilled water, and stored at 70°C. For additional purification of spores,
primarily to remove vegetative debris, the procedure described by Nicholson and
Setlow (20) was used with modification (33). Washed spores (25 mg) were sus-
pended in a 70% Renografin (Sigma Aldrich, St. Louis, MO) solution to a final
concentration of 50%. The Renografin spore suspension was placed on ice for
1 h then layered on top of the thawed gradient and centrifuged at 5,000  g for
45 min. A stock solution (75% solution of Renografin) was first used to generate
a series of dilutions (varying from 45% to 55%). Each layer was frozen at 70°C
for 10 min before the next layer was applied. In early experiments, cells were
grown in nutrient broth (Difco) and shaken at 37°C. Vegetative cells were
harvested after 6 to 12 h growth and spores were essentially absent. Spores were
harvested after 7 to 10 days growth, when cultures were 90 to 95% spores.
Ultrastructural characterization of exosporium. To the buffer-washed spores
or urea-extracted spores (see section below for details), 1 ml of a 2.5% glutar-
aldehyde, 0.1 M sodium cacodylate solution containing 0.1% ruthenium red
(Electron Microscopy Sciences, Fort Washington, PA) was added and incubated
for 1 hour at 37°C. Each pellet was then washed in sodium phosphate buffer
(PBS, Fisher Scientific, Norcross, GA) and fixed for 3 h at room temperature in
a 2% osmium tetroxide (Electron Microscopy Sciences), 0.1 M sodium cacody-
late solution containing 0.1% ruthenium red. A negative control was treated
identically, but ruthenium red was omitted from these two steps.
Spores were washed in buffer and embedded in 3% agar (EM Science, Gibbs-
town, NJ). Dehydration involved sequential treatment with 25, 50, 75, 95, and
100% ethanol (AAPER Alcohol & Chemical Co., Shelbyville, KY). Afterwards,
cells were placed sequentially in propylene oxide (Electron Microscopy Sci-
ences), propylene oxide/Polybed 812 (2:1) and pure Polybed 812 (Polysciences,
Warrington, PA). Polymerization was carried out at 60°C in pure Polybed.
Specimen blocks were thin-sectioned (120 nm thick) and then collected on
200-mesh copper grids, and electron microscopy sections were cut and then
stained with a 2% uranyl acetate solution (Electron Microscopy Sciences) for 40
min at 37°C. The sections were then treated with Hanaichi lead citrate (0.15%
lead nitrate, 0.15% sodium acetate, 1% sodium citrate dissolved in 41 ml water
and 9 ml of 1 N sodium hydroxide [Fisher Scientific]) for 2 min. Spores were
observed by transmission electron microscopy (33).
Analysis of glycoproteins using SDS-PAGE. We extracted 50 mg (wet weight)
of B. anthracis spores with a urea buffer (50 mM Tris-HCl, pH 10, 8 M urea, 2%
2-mercaptoethanol) (Fisher Scientific) for 15 min at 90°C. The extracted spores
were centrifuged at 13,000  g for 10 min at room temperature. The supernatant
was removed and filtered by centrifugation through Microcon filters (100-kDa
cutoff, Millipore, Bedford, MA). The Microcon filter holders were filled with
PBS and centrifuged almost to dryness. This was repeated two additional times,
and the retentate was stored for protein analysis. In some experiments, glyco-
proteins were additionally deglycosylated with trifluoromethanesulfonic acid
(TFMS). Glycoproteins were lyophilized, and anisole:TFMS (1:9 ratio) (Fisher
Scientific) was added to the samples. Samples were flushed with N2 and vacuum
in order to provide an anhydrous environment for deglycosylation.
After 72 h deglycosylation at 4°C, the reaction was quenched by adding a
twofold excess of ice-cold ether (Fisher Scientific) followed by dropwise addition
of an equal volume of ice-cold 50% aqueous pyridine (Alltech, Deerfield, IL). In
order to recover the deglycosylated proteins, the ether layer was discarded, and
the ether extraction was repeated in order for further cleanup of samples. Spore
protein extracts were combined with loading buffer (50 mM Tris-HCl, pH 6.8,
4% sodium dodecyl sulfate [SDS], 10% glycerol, 5% -mercaptoethanol, 0.02%
bromophenol blue [Fisher Scientific]), loaded onto each lane of 4 to 15% gra-
dient polyacrylamide gels (Jule, Inc., Milliford, CT), and electrophoresed in
Tris-glycine-SDS buffer (Fisher Scientific). The gels were stained with a Gelcode
Blue staining kit (Pierce, Rockford, IL).
Prior to glycoprotein analysis, gels were equilibrated in cathode buffer (25 mM
Tris, pH 9.4, 40 mM glycine, 0.01% SDS, 20% methanol) (Fisher Scientific). For
glycoprotein staining, the proteins in the gel were transferred onto a polyvinyl-
idene difluoride membrane (Millipore) using a semidry transfer apparatus (Mil-
lipore). The membranes were processed using the ECL glycoprotein detection
system (Amersham Biosciences, Piscataway, NJ) to identify glycoprotein bands.
In preparative experiments, one gel lane was processed using the ECL glycopro-
tein detection system (Amersham Biosciences) to identify the glycoprotein band
and the other eight lanes left unstained. The membrane was incubated in PBS for
10 min and then 20 min in the dark in 100 mM sodium metaperiodate (Amer-
sham Biosciences) and 100 mM acetate buffer, pH 5.5 [Fisher Scientific]. The
membrane was washed and then incubated for 60 min in a 24 nM solution of
biotin hydrazide in 100 mM acetate buffer, pH 5.5. The membrane was washed
again in PBS and then placed in blocking agent overnight at 4°C. The blocked
membrane was washed in PBS and incubated in a 1:6,000 dilution of streptavidin-
horseradish peroxidase conjugate for 30 min. The filter was then washed with
PBS, exposed to enzyme substrate (ECL Western Blotting Detection System) for
1 min, and placed against autoradiographic film (Hyperfilm ECL, Amersham
Biosciences) and exposed for 2 min.
Analysis of the protein moiety of glycoproteins using MALDI-TOF MS. After
Coomassie blue staining of gels as described above, the appropriate bands were
excised from the gel with a razor blade and destained with a 50:50 mixture of
acetonitrile (Fisher Scientific) and 25 mM ammonium bicarbonate (Sigma). A
blank gel piece was similarly treated as a negative control. After destaining the
gel pieces were dehydrated with 100% acetonitrile for 10 min and then dried
under N2. Next, the gel pieces were incubated for 30 min in 10 mM dithiothreitol
(Sigma Aldrich). The dithiothreitol solutions were removed and the pieces were
incubated in iodoacetamide (Sigma Aldrich) for 30 min. The gel pieces were then
washed with 100 mM ammonium bicarbonate solution for 10 min followed by
two dehydrations with acetonitrile. The gels were rehydrated with100 mM am-
monium bicarbonate for 10 min. Finally, the gel slices were again dehydrated
twice using acetonitrile and allowed to dry under N2.
The gel slices were prepared for enzymatic digestion by rehydration with 100
mM ammonium bicarbonate for 10 min. The rehydration solution was removed
and then a solution of 0.4% pepsin (Sigma Aldrich) in 10 mM HCl was added.
The digestion occurred for approximately 90 min at 37°C. Trypsin is the most
commonly used enzyme for protein digestion prior to mass spectrometry (MS)
analysis. However, there are very few trypsin sites in ExsH-like proteins. After
digestion the samples were then spotted on a matrix-assisted laser desorption
ionization-time of flight (MALDI-TOF) target plate along with the MALDI
matrix -cyano-4-hydroxycinnamic acid (HCCA) (Sigma Aldrich). A Micromass
Biolynx (Waters Corporation, Beverly, MA) linear time-of-flight instrument was
used for mass spectrometry analysis. The resulting mass spectra were interpreted
using Protein Prospector software (http://prospector.ucsf.edu).
Analysis of the carbohydrate portion of glycoproteins using GC-MS and
GC-MS-MS. Polyvinylidene difluoride membranes were washed three times in
PBS and then water. The BclA and other bands were excised with a scalpel blade
and placed in 2 N sulfuric acid (Fisher Scientific). Four lanes were pooled (140
	g) and analyzed in duplicate. For comparison, 10 mg of spores was also ana-
lyzed in duplicate. The samples were then heated at 100°C for 3 h. Arabinose and
methylglucamine (Sigma Aldrich) were used as internal standards (500 ng for
bands, 50 	g each for spores). For neutralization and hydrophobic prederivat-
ization clean-up, samples were neutralized with 50% N,N-dioctylmethylamine
(Sigma Aldrich) in chloroform, followed by aqueous phase extraction using C-18
columns (Agilent Technologies, Wilmington, DE).
Samples were reduced overnight with sodium borodeuteride (Sigma Aldrich)
at 4°C. Borodeuteride was removed, as tetramethylborate gas, by multiple meth-
anol-acetic acid (200:1) (Fisher Scientific) evaporations under nitrogen. Samples
were then dried under vacuum for 3 h at 60°C. The alditols were acetylated by
heating at 100°C for 15 h with acetic anhydride (Alltech, Deerfield, IL). Hydro-
philic postderivatization clean-up included acid and alkaline extractions. Gas
chromatography-mass spectrometry (GC-MS) analysis was carried out with a
mass-selective detector in electron impact mode (Hewlett Packard model 5970;
Agilent) equipped with an automated sample injector and a DB5ms fused-silica
capillary column (Agilent). Gas chromatography-tandem mass spectrometry
(GC-MS-MS) was performed using an ion trap tandem mass spectrometer (GCQ,
Finnigan, Atlanta, GA). Ionization was performed in electron impact mode followed
by collision-induced dissociation and multiple reaction monitoring (8).
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RESULTS
The primary goal was to identify a second glycoprotein pro-
duced by B. anthracis. Once this was established, then the
second goal was to determine whether spore-specific sugars
(rhamnose, 3-O-methyl rhamnose, and galactosamine) (8, 38)
are components of this glycoprotein. Others have determined
the carbohydrate composition of BclA, the first glycoprotein
discovered in B. anthracis (4), but a second collagen-like gly-
coprotein has not previously been identified in this organism.
On electron microscopy observation of untreated spores,
after ruthenium red staining, the exosporium is observed as a
distinct carbohydrate-rich layer surrounding the underlying
coat. After urea treatment the exosporium layer was disrupted
but the spore remained otherwise intact. In these studies, cells
were grown in nutrient broth. This avoided the possibility of
agar, which consists largely of carbohydrate, adhering to spore
surfaces and affecting electron microscopy morphology.
An approach was taken to focus on spore-specific glycopro-
teins in the urea extract. Spores and vegetative cells (each
99%, agar grown) were extracted with urea and their protein
and glycoprotein profiles compared. In each case, bands of
250 kDa (previously identified as BclA) (29, 30) and 205 kDa
(not previously identified in B. anthracis) were observed in
spores but were absent in vegetative cells. The 250-kDa species
was by far the most abundant spore protein (see Fig. 1). The
gels were stained with a Gelcode Blue staining kit that stained
both BclA and the 205-kDa bands. BclA does not stain with
conventional Coomassie blue, as noted by others (29). Spores
were further purified using Renografin gradients and both
bands were still present. On deglycosylation the two bands
disappeared and were replaced by two new smaller bands (83
and 71 kDa, respectively; data not shown).
Others have previously identified the 250-kDa band by
N-terminal sequencing as BclA (30). The excised 205-kDa
bands were subjected to in situ digestion with pepsin and re-
leased peptides were analyzed by MALDI-TOF MS. Five pep-
tides had measured masses predicted to be generated from an
ExsH-like protein coded by the genome of B. anthracis strain
Sterne (hypothetical protein BAS2281); measured: 991.5,
1034.1, 1194.8, 1222.7; 1264.3; predicted: 992.0, 1034.2, 1192.4,
1221.5, 1263.4 (see Fig. 2). These masses would be consistent
with peptides sequences TGPTGTTGATGA or TGATGPTG
TTGA, TILPGVVGDY, MKQNDKLWL (methionine oxi-
dized), TPVQIQMQIF (methionine oxidized), and TGVTGA
TGITGVTGA, respectively.
Using GC-MS, 3-O-methyl rhamnose, rhamnose, and galac-
tosamine were confirmed to be components of isolated BclA,
as demonstrated by others (4). GC-MS-MS was needed for
definitive identification of sugars in ExsH-like bands, as BclB is
present at such low concentrations. The parent ion (MS-MS
spectrum) for rhamnose is mass 231 and the major fragments
are 189 (loss of ketene, mass 42) and 129 (loss of 60). The
presence of 3-O-methyl rhamnose in spore 205-kDa bands was
also confirmed. The parent ion for 3-O-methyl rhamnose is 203
kDa and the major fragments are 143 kDa (loss of acetic acid)
and 101 kDa (loss of ketene). The major masses, 143 and 101
Da, were prominent (in the peak at the retention for 3-O-
methyl rhamnose) in the hydrolysate of the 205-kDa bands.
Galactosamine was also demonstrated to be present in the
205-kDa bands; 53 ng rhamnose, 4 ng of 3-O-methyl rhamnose
and 42 ng of galactosamine were present in the combined
205-kDa bands, an order of magnitude lower than in the BclA
bands. Thus, we can clearly state that these spore-specific sug-
ars are also derived from the 205-kDa species. In conclusion,
rhamnose, 3-O-methyl rhamnose, and galactosamine are also
components of the 205-kDa bands (ExsH-like protein).
FIG. 1. (A) Vegetative cell and spore proteins separated by elec-
trophoresis and stained for proteins with Gel Code Blue reagent. (B)
The gel shows spore extracts separated by electrophoresis and stained
for glycoproteins.
FIG. 2. Size of pepsin-digested bands in (A) control and (B) 205-
kDa protein. The analysis was performed by MALDI-TOF MS. Five
peptides are present that have measured masses similar to those pre-
dicted to be produced from the anthrax ExsH-like protein (BclB).
Measured: 991.5, 1034.1, 1194.8, 1222.7; 1264.3; predicted, 992.0, 1034.2,
1192.4, 1221.5, 1263.4.
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FIG. 3. Sequences of ExsH-like proteins, including BclB, of B. anthracis (Ba), B. cereus (Bc), and B. thuringiensis (Bt). The N terminus is marked
in blue, the GXX repeat region is in green, and the C terminus is in orange. BclB repeat regions (GITGVTGAT) are marked in black.
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DISCUSSION
In the current report, it is demonstrated that the B. anthracis
spore contains a second collagen-like glycoprotein, BclB. Fur-
thermore, it is demonstrated that spore-specific sugars are also
components of this glycoprotein. We have previously shown
that rhamnose, 3-O-methyl rhamnose, and galactosamine are
readily detected in spores but not vegetative cells of B. anthra-
cis (8). Others subsequently demonstrated that the spore-spe-
cific sugars (galactosamine, rhamnose, and 3-O-methyl rham-
nose, along with anthrose) are components of BclA (4).
BclA from the Sterne strain migrates in SDS-PAGE gels
with an apparent size of 250 kDa (29, 30). Previously, others
reported, after partial deglycosylation of BclA, an 80-kDa band
was observed (30). The presence of a second partially degly-
cosylated band of 71 kDa is described here and presumably de-
rived from BclB. BclA and BclB (hypothetical protein BAS2281
of the Sterne strain) would be predicted, from their sequences,
to have protein backbones 39 and 32 kDa in size, respectively.
There is considerable size heterogeneity among the BclA pro-
teins due to different numbers of GPT repeats and [GPT]5
GDTGTT repeats in the protein. The 21-amino-acid repeat has
been named the BclA repeat (31). These repeats are believed
to be the primary anchor point for rhamnose oligosaccharides
within BclA (4). Size diversity in BclB proteins has not been
studied, but from the genomic sequences, BclB coded by
the Ames strain (hypothetical protein GBBA2450) contains
six GXX repeats not present in Sterne (hypothetical protein
BAS2281).
A B. anthracis 205-kDa glycoprotein has not been previously
identified. A 205-kDa glycoprotein isolated from the exospor-
ium of B. thuringiensis has the N-terminal sequence MKHN
DXF (10). A 205-kDa glycoprotein has also been identified in
B. cereus with the N-terminal sequence MKHNDCFXHNNC
NPIVF (32). The region referred to as exsH was sequenced and
codes for a collagen-like domain primarily of GATs, with a few
GPT repeats (32).
Using the sequences of Todd and coworkers (32), a BLAST
search was performed for all additional related sequences
coded by the genomes of B. anthracis, B. cereus, and B. thur-
ingiensis (see Fig. 3). Thirteen proteins were found in all which
contained GXX repeat sequences related to ExsH. The N ter-
mini of seven Exs-H like proteins (including the four found in
B. anthracis) showed homology. The C termini of 11/13 pro-
teins (including all four B. anthracis proteins) also shared ho-
mology. There is also a BclB repeat (in analogy to the BclA
repeat), GITGVTGAT, not found in B. cereus or B. thuringien-
sis proteins. It appears that the anthrax ExsH-like protein
might have initially resulted from a recombination event which
merged the N and C termini from the two types of exs-H like
genes derived from a strain of B. cereus or B. thuringiensis and
created a unique gene, bclB (Bacillus collagen-like protein
gene B). In the current work, using MALDI TOF MS analysis,
five peptides were identified in pepsin digests of the 205-kDa
band (Sterne strain) that would be consistent with masses
predicted to be generated from an ExsH-like protein coded by
the genome of B. anthracis strain Sterne (protein BAS2281).
A gene cluster consisting of 11 open reading frames has been
identified that contains the BclA glycoprotein structural pro-
tein (orf4) (9). Several of these B. anthracis genes show homol-
ogy with those of Aneurinibacillus thermoaerophilus which are
involved in synthesis of rhamnose and 3-O-methyl rhamnose,
which are also components of a cell surface glycoprotein (27).
An ExsH glycoprotein gene synthesis cluster has not yet
been identified.
The two well-established anthrax pathogenesis factors are
the tripartite toxin (22) and the vegetative cell polyglutamic
acid capsule (11, 21). It has been suggested that the current
vaccine against the protective antigen component of lethal tox-
in may not be fully protective (2, 7, 17, 35–37). Recent reports
have focused on the need for a conjugate vaccine, additionally
targeting the vegetative cell (23, 28). Indeed, a possible candi-
date conjugate vaccine consisting of polyglutamic acid and pro-
tective antigen is quite reasonable and deserves exploration.
However, there is good evidence that the protective antigen
vaccine does not provide complete protection in animal models
and survival is substantially increased by the inclusion of for-
malin-fixed spores on immunization (2). Thus, other candi-
dates for inclusion in a conjugate vaccine might be spore pro-
teins, including BclB.
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